tiprankstipranks
Verastem Inc (VSTM)
NASDAQ:VSTM
US Market
VSTM
Verastem
RESEARCH TOOLSreports
Want to see VSTM full AI Analyst Report?

Verastem (VSTM) Stock Forecast & Price Target

2,032 Followers
See the Price Targets and Ratings of:

VSTM Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Verastem
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VSTM Stock 12 Month Forecast

Average Price Target

$16.00
▲(143.16% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Verastem in the last 3 months. The average price target is $16.00 with a high forecast of $18.00 and a low forecast of $14.00. The average price target represents a 143.16% change from the last price of $6.58.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","7":"$7","11":"$11","15":"$15","19":"$19"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$18.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,7,11,15,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.84,6.775384615384615,7.71076923076923,8.646153846153846,9.581538461538461,10.516923076923078,11.452307692307691,12.387692307692308,13.323076923076922,14.258461538461539,15.193846153846154,16.12923076923077,17.064615384615387,{"y":18,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.84,6.621538461538462,7.403076923076923,8.184615384615384,8.966153846153846,9.747692307692308,10.529230769230768,11.31076923076923,12.092307692307692,12.873846153846154,13.655384615384616,14.436923076923076,15.218461538461538,{"y":16,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.84,6.467692307692308,7.095384615384615,7.723076923076922,8.350769230769231,8.978461538461538,9.606153846153845,10.233846153846153,10.861538461538462,11.489230769230769,12.116923076923076,12.744615384615384,13.372307692307691,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.43,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.02,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.29,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.08,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.22,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.34,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.72,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.25,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.82,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.55,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.84,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$18.00Average Price Target$16.00Lowest Price Target$14.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on VSTM
Graig Suvannavejh
Mizuho Securities
Mizuho Securities
$16→$14
Buy
112.77%
Upside
Reiterated
05/13/26
Analysts' Top Healthcare Picks: Verastem (VSTM), PDS Biotechnology (PDSB)
H.C. Wainwright Analyst forecast on VSTM
Andres Y. Maldonado
H.C. Wainwright
H.C. Wainwright
$18
Buy
173.56%
Upside
Reiterated
05/08/26
H.C. Wainwright Keeps Their Buy Rating on Verastem (VSTM)
BTIG Analyst forecast on VSTM
Jeet Mukherjee
BTIG
BTIG
$19→$18
Buy
173.56%
Upside
Reiterated
05/08/26
Verastem price target lowered to $18 from $19 at BTIGVerastem price target lowered to $18 from $19 at BTIG
Alliance Global Partners Analyst forecast on VSTM
James Molloy
Alliance Global Partners
Alliance Global Partners
$16→$18
Buy
173.56%
Upside
Reiterated
05/08/26
Verastem price target raised to $18 from $16 at Alliance GlobalVerastem price target raised to $18 from $16 at Alliance Global
Guggenheim Analyst forecast on VSTM
Michael Schmidt
Guggenheim
Guggenheim
$14
Buy
112.77%
Upside
Reiterated
05/07/26
Guggenheim Reaffirms Their Buy Rating on Verastem (VSTM)
RBC Capital Analyst forecast on VSTM
Leonid Timashev
RBC Capital
RBC Capital
$15
Buy
127.96%
Upside
Reiterated
05/07/26
Verastem (VSTM) Receives a Buy from RBC Capital
Jefferies Analyst forecast on VSTM
Faisal Khurshid
Jefferies
Jefferies
$19→$15
Buy
127.96%
Upside
Initiated
03/30/26
Verastem assumed with a Buy at JefferiesVerastem assumed with a Buy at Jefferies
Cantor Fitzgerald Analyst forecast on VSTM
Eric Schmidt FCA
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Initiated
10/16/25
Verastem assumed with an Overweight at Cantor FitzgeraldVerastem assumed with an Overweight at Cantor Fitzgerald
Wolfe Research Analyst forecast on VSTM
Kalpit Patel
Wolfe Research
Wolfe Research
$16
Buy
143.16%
Upside
Reiterated
10/10/25
B. Riley Securities Reaffirms Their Buy Rating on Verastem (VSTM)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on VSTM
Graig Suvannavejh
Mizuho Securities
Mizuho Securities
$16→$14
Buy
112.77%
Upside
Reiterated
05/13/26
Analysts' Top Healthcare Picks: Verastem (VSTM), PDS Biotechnology (PDSB)
H.C. Wainwright Analyst forecast on VSTM
Andres Y. Maldonado
H.C. Wainwright
H.C. Wainwright
$18
Buy
173.56%
Upside
Reiterated
05/08/26
H.C. Wainwright Keeps Their Buy Rating on Verastem (VSTM)
BTIG Analyst forecast on VSTM
Jeet Mukherjee
BTIG
BTIG
$19→$18
Buy
173.56%
Upside
Reiterated
05/08/26
Verastem price target lowered to $18 from $19 at BTIGVerastem price target lowered to $18 from $19 at BTIG
Alliance Global Partners Analyst forecast on VSTM
James Molloy
Alliance Global Partners
Alliance Global Partners
$16→$18
Buy
173.56%
Upside
Reiterated
05/08/26
Verastem price target raised to $18 from $16 at Alliance GlobalVerastem price target raised to $18 from $16 at Alliance Global
Guggenheim Analyst forecast on VSTM
Michael Schmidt
Guggenheim
Guggenheim
$14
Buy
112.77%
Upside
Reiterated
05/07/26
Guggenheim Reaffirms Their Buy Rating on Verastem (VSTM)
RBC Capital Analyst forecast on VSTM
Leonid Timashev
RBC Capital
RBC Capital
$15
Buy
127.96%
Upside
Reiterated
05/07/26
Verastem (VSTM) Receives a Buy from RBC Capital
Jefferies Analyst forecast on VSTM
Faisal Khurshid
Jefferies
Jefferies
$19→$15
Buy
127.96%
Upside
Initiated
03/30/26
Verastem assumed with a Buy at JefferiesVerastem assumed with a Buy at Jefferies
Cantor Fitzgerald Analyst forecast on VSTM
Eric Schmidt FCA
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Initiated
10/16/25
Verastem assumed with an Overweight at Cantor FitzgeraldVerastem assumed with an Overweight at Cantor Fitzgerald
Wolfe Research Analyst forecast on VSTM
Kalpit Patel
Wolfe Research
Wolfe Research
$16
Buy
143.16%
Upside
Reiterated
10/10/25
B. Riley Securities Reaffirms Their Buy Rating on Verastem (VSTM)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Verastem

3 Months
Kalpit PatelWolfe Research
Success Rate
3/7 ratings generated profit
43%
Average Return
+11.80%
Copying Kalpit Patel's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +11.80% per trade.
1 Year
James MolloyAlliance Global Partners
Success Rate
2/7 ratings generated profit
29%
Average Return
+12.66%
Copying James Molloy's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of +12.66% per trade.
2 Years
Kalpit PatelWolfe Research
Success Rate
2/7 ratings generated profit
29%
Average Return
-21.01%
Copying Kalpit Patel's trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of -21.01% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VSTM Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
9
12
20
21
22
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
12
20
21
22
In the current month, VSTM has received 22 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VSTM average Analyst price target in the past 3 months is 16.00.
Each month's total comprises the sum of three months' worth of ratings.

VSTM Financial Forecast

VSTM Earnings Forecast

Next quarter’s earnings estimate for VSTM is -$0.43 with a range of -$0.45 to -$0.37. The previous quarter’s EPS was -$0.37. VSTM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year VSTM has Performed in-line its overall industry.
Next quarter’s earnings estimate for VSTM is -$0.43 with a range of -$0.45 to -$0.37. The previous quarter’s EPS was -$0.37. VSTM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year VSTM has Performed in-line its overall industry.

VSTM Sales Forecast

Next quarter’s sales forecast for VSTM is $23.50M with a range of $22.10M to $26.10M. The previous quarter’s sales results were $18.67M. VSTM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year VSTM has Performed in-line its overall industry.
Next quarter’s sales forecast for VSTM is $23.50M with a range of $22.10M to $26.10M. The previous quarter’s sales results were $18.67M. VSTM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year VSTM has Performed in-line its overall industry.

VSTM Stock Forecast FAQ

What is VSTM’s average 12-month price target, according to analysts?
Based on analyst ratings, Verastem Inc’s 12-month average price target is 16.00.
    What is VSTM’s upside potential, based on the analysts’ average price target?
    Verastem Inc has 143.16% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is VSTM a Buy, Sell or Hold?
          Verastem Inc has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Verastem Inc’s price target?
            The average price target for Verastem Inc is 16.00. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $18.00 ,the lowest forecast is $14.00. The average price target represents 143.16% Increase from the current price of $6.58.
              What do analysts say about Verastem Inc?
              Verastem Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of VSTM?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.